Artificial Intelligence in Cancer Management: Promise, Pragmatism, and Preparedness

Authors

  • Mostafa Robatjazi Non-communicable Disease Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Fatemeh Musavi Ergonomics department, Faculty of Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Alireza Ghorbani Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Navid Sarmast Alizadeh MRI center, Auckland City Hospital, Auckland, New Zealand.

DOI:

https://doi.org/10.31557/apjcc.2026.11.3.325-327

Keywords:

Artificial Intelligence, Cancer Managment

Abstract

Artificial intelligence is transforming cancer detection, treatment planning, and decision support, yet its rapid adoption risks outstripping validation, ethical safeguards, and economic sustainability. Key challenges include algorithmic bias, generalizability failures, opaque liability, and high implementation costs. Responsible integration demands clinician involvement, fairness-aware development, dynamic consent, and adaptive reimbursement. AI will augment, not replace oncologists, but its success hinges on rigorous governance and patient-centered scrutiny.

Downloads

Published

2026-05-02

How to Cite

Robatjazi, M., Musavi, F., Ghorbani, A., & Sarmast Alizadeh, N. (2026). Artificial Intelligence in Cancer Management: Promise, Pragmatism, and Preparedness. Asian Pacific Journal of Cancer Care, 11(3), 325–327. https://doi.org/10.31557/apjcc.2026.11.3.325-327

Issue

Vol. 11 No. 3 (2026)

Section

Editorial